By Chris Weller | Tue, 11/26/2013 - 16:00
Immune-modulating drug thalidomide induced clinical remission for pediatric Crohn's disease sufferers for more than 180 weeks.
By Chris Weller | Tue, 10/22/2013 - 11:37
Shreddies underwear uses chemical warfare technology to trap odor particles that are up to 200 times stronger than the average fart.
By Nsikan Akpan | Wed, 08/21/2013 - 17:37
Two studies show promising results for vedolizumab as a drug candidate for Crohn’s disease and ulcerative colitis.
By Jonathan Weiss | Thu, 06/27/2013 - 12:42
Adding a second piece to the puzzle of Crohn's disease, scientists have linked the condition to enterovirus in children.
By Ansa Varughese | Mon, 06/03/2013 - 16:39
NIH researchers linked altered BACH2 genes to cases of Crohn's disease, type 1 diabetes, celiac disease, and asthma, among other autoimmune disorders.
By Christie Rizk | Mon, 05/20/2013 - 14:25
A new study suggests it may be possible to test for potential side effects of the Crohn's disease drug infliximab before treatment is administered.
By Christie Rizk | Tue, 05/14/2013 - 11:00
Treatment through cannabis may be beneficial to patients with Crohn's disease, new research finds.
By Ashik Siddique | Fri, 03/22/2013 - 18:00
The genes that lead to autoimmune inflammatory diseases like MS, Crohn’s disease, and rheumatoid arthritis may have actually benefited our early ancestors– more evidence for the hygiene hypothesis.
By Makini Brice | Fri, 08/24/2012 - 16:29
Massachusetts-based company Coronado Biosciences is developing a new class of treatments to fight autoimmune disorders.